News Focus
News Focus
Post# of 257403
Next 10
Followers 843
Posts 122865
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 192970

Friday, 08/21/2015 9:27:32 AM

Friday, August 21, 2015 9:27:32 AM

Post# of 257403
ADXS, AZN start phase-2 trial of ADXS-HPV + Durvalumab (AZN’s checkpoint inhibitor) in HPV-associated (cervical, H&N) cancers:

http://finance.yahoo.com/news/advaxis-medimmune-commence-enrollment-phase-130500622.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today